Bibliographic information

GuidelineClinical management of COVID-19: living guideline, June 2025
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Maintained

In hospitalized patients with severe or critical COVID-19 and acute hypoxaemic respiratory failure (AHRF) not needing emergent intubation, we suggest non-invasive ventilation, rather than standard oxygen therapy

Recommended in favor

Conditional

Notes and Remarks

The GDG chose not to make a recommendation regarding optimal interface for NIV, whether helmet or face mask, given the limited data. The choice between interface should be guided by clinician experience, availability, and patient comfort. The GDG chose not to make a recommendation regarding HFNO versus CPAP versus NIV due to the uncertainty of the data. Clinicians should choose on the basis of considerations such as availability of devices and the supply of oxygen, their personal comfort and experience, and patient-specific considerations (such as claustrophobia that some patients experience with CPAP/ NIV masks, and nasal discomfort that some patients experience with HFNO). Given the likely similar direction of benefit, the GDG elected to extend this recommendation to the paediatric age range (despite the absence of randomized trial data), while emphasizing the need for more research in this population.

Practical info There is no specific recommendation for the initial settings to be used for non-invasive ventilation, with local experience and patient-specific factors informing decisions and manufacturer instructions. Based on clinical experience of the GDG, there is a suggestion to start with an expiratory positive airway pressure of 5–10 cmH2O, an inspiratory positive airway pressure to achieve a tidal volume of ~6 ml/kg, titration of both settings to patient comfort and work of breathing, and titration of FiO2 to achieve the target oxygen saturation when using facemask or oral-nasal mask. For use of helmet interfaces, additional information can be found in recent publications (235). For infection prevention precautions related to the use of these respiratory support devices, please refer to Chapter 5 on IPC. See also Research needs.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Clinical management of COVID-19: living guideline, 15 September 2022.

Year2022
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 13 January 2023.

Year2023
InstitutionWHO